fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Abbott India Ltd

Abbott India Ltd

Updated on October 15, 2020

Stock/Share Code - ABBOTINDIA

Abbott India is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.(Source : 201903 Annual Report Page No: 58)

Below is the details of ABBOTINDIA Abbott India Ltd

Market Cap₹34,811 Cr.
Current Price ₹15,885.15 as on 21 Oct 20
52 Week High / Low Price₹18,679.75 / ₹9,150
Face Value₹10
Stock P/E53.04
Book Value₹1,144
Dividend Yield0.65 %
ROCE35.18 %
ROE26.73 %
Sales Growth (3yrs)12.14 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has delivered good profit growth of 21.10% CAGR over last 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 25.65% Company has been maintaining a healthy dividend payout of 49.80%
Cons: Stock is trading at 14.31 times its book value

Abbott India Ltd Price Chart

Abbott India Ltd Price Chart

Abbott India Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Abbott India ₹274.95 53.02 ₹34,801.34 Cr. 0.65 ₹180.35 Cr. 54.22 6.55 1064.27 35.18
2. Glaxosmi. Pharma ₹50.45 64.27 ₹26,534.07 Cr. 1.28 ₹110.83 Cr. -2.39 -17.69 648.59 32.88
3. Pfizer ₹5,010.7 40.38 ₹21,026.57 Cr. 0.22 ₹124.45 Cr. 10.32 -5.42 514.89 20.42
4. Sanofi India ₹8,341.6 36.70 ₹18,927.32 Cr. 1.28 ₹136.3 Cr. 39.16 -5.00 710.50 28.38
5. Astrazeneca Phar ₹4,294.25 128.00 ₹8,874.38 Cr. 0.06 ₹18.63 Cr. -13.43 -5.37 193.58 33.92
6. P & G Health Ltd ₹3.85 48.40 ₹7,962.94 Cr. 0.00 ₹46.46 Cr. 14.12 -1.26 228.11 19.89
7. Novartis India ₹274.95 112.15 ₹1,534.16 Cr. 1.61 ₹4.39 Cr. 455.70 -15.41 92.46 4.53

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Abbott India Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -9318817888459809489069991,0551,0789611,064
YOY Sales Growth %29.10%18.08%11.72%21.10%5.24%7.51%14.96%18.22%7.66%13.78%6.06%6.55%
Expenses -730718682734786801753825851839823831
Material Cost %56%58%55%56%57%58%56%56%57%55%58%57%
Employee Cost %11%10%14%14%11%11%12%12%11%11%12%12%
Operating Profit201163107111194146153174204240138233
OPM %22%19%14%13%20%15%17%17%19%22%14%22%
Other Income151959222538293029282828
Interest112110122234
Depreciation44444451515151514
Profit before tax212178159129214180177187216251149242
Tax %35%35%37%36%36%35%36%37%18%25%25%26%
Net Profit13811510082138117113117178187111180
EPS in Rs64.7254.3047.1038.7864.7955.0853.2855.0383.9287.8552.2284.87
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -6667619901,4901,6532,2762,2892,6142,9033,2983,6794,0934,159
Sales Growth %12.06%14.25%30.09%50.54%10.90%37.71%0.59%14.20%11.02%13.64%11.52%11.27%
Expenses -5906639201,3151,4702,0091,9772,2502,5052,7743,0743,3363,343
Material Cost %68%66%65%58%59%57%57%57%59%58%57%57%
Manufacturing Cost %2%2%2%1%1%1%1%1%1%1%1%2%
Employee Cost %7%8%11%11%12%13%13%13%12%12%12%12%
Other Cost %11%11%15%18%17%17%15%15%15%13%14%12%
Operating Profit769770176183267312365398525605757816
OPM %11%13%7%12%11%12%14%14%14%16%16%18%20%
Other Income262936205149485057117113114112
Interest00000003242911
Depreciation791115192215141616176059
Profit before tax9411794180215295344398436621699803858
Tax %33%34%35%33%33%33%34%36%37%35%36%26%
Net Profit637861120145198229255277401450593656
EPS in Rs43.5853.7738.5253.9065.3471.59101.44120.12130.19188.81211.93279.04308.86
Dividend Payout %30%30%38%30%25%25%29%29%31%29%31%90%

Compounded Sales Growth

  • 10 Years:: 18.32%
  • 5 Years:: 12.32%
  • 3 Years:: 12.14%
  • TTM:: 8.50%

Compounded Profit Growth

  • 10 Years:: 22.55%
  • 5 Years:: 21.10%
  • 3 Years:: 28.94%
  • TTM:: 35.37%

Return on Equity

  • 10 Years:: 30.65%
  • 5 Years:: 26.76%
  • 3 Years:: 57.68%
  • 1 Year:: 79.01%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -141414212121212121212121
Equity Capital13.6813.6813.6821.2521.2521.2521.2521.2521.2521.2521.2521.25
Reserves2082582925236267679161,1741,3661,6721,9872,410
Borrowings10000000000175
Other Liabilities -129117148253260351436421679723932940
Trade Payables714358121101136194230475481664658
Advance from Customers-0-0-0111002255
Other liability items577390131158214242191202240263277
Total Liabilities3513884537979071,1391,3741,6162,0662,4162,9413,547
Fixed Assets -48495080109989610811081105270
Gross Block99107118192204209216123140124164345
Accumulated Depreciation515868112951111201430435975
CWIP301011436212
Investments000000000000
Other Assets -3003394037177981,0401,2741,5051,9502,3332,8353,275
Inventories92102129255264359384370501585607527
Trade receivables324465133141109129145176263276318
Cash Equivalents1641761892593234636448391,0911,0311,6842,197
Loans n Advances14192450577884115147412221186
Other asset items-2-3-4211330323535414747
Total Assets3513884537979071,1391,3741,6162,0662,4162,9413,547

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -87374624101155215249307153499626
Profit from operations92122101182206293307374399545621785
Receivables-5-13-23-52-1127-22-16-34-88-13-42
Inventory-6-10-26-73-9-103-2514-131-85-2180
Payables42-244343-173556392475186-9
Loans Advances000-15-8-5-10-16-23-2746
Other WC items000051716-16-0410-6
Working capital changes31-46-6-97-40-28232267-18713470
Direct taxes-36-38-49-60-65-110-116-147-159-205-257-229
Cash from Investing Activity -140-1-1656-59-144-187-77-155-215-257-401
Fixed assets purchased-21-8-12-16-17-18-18-23-21-24-12-16
Fixed assets sold000001430052170
Investments purchased-2400-000000000
Investments sold180003700000000
Interest received6661523324050556393120
Dividends received000100000000
Inter corporate deposits00000000-189-105-554-506
Other investing items01-1019-65-172-211-105-1-2002000
Cash from Financing Activity --81-23-27-42-42-42-58-80-90-102-143-217
Repayment of borrowings-0-10000000000
Interest paid fin-0-0-0-0-0-0-0-1-0-0-2-0
Dividends paid-30-22-27-42-42-42-49-66-74-85-117-138
Financial liabilities00000000000-50
Other financing items-5100000-9-13-15-17-24-28
Net Cash Flow146133381-31-309162-165998

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %40%48%33%42%34%39%40%38%34%41%37%35%
Debtor Days182124323118212022292728
Inventory Turnover5.165.245.674.543.784.203.553.973.953.533.534.11

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Abbott India Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.